CDC panel recommends Moderna, J&J vaccine boosters for certain adults

Oct 21, 2021 - 01:42 PM
cdc-update

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices today voted unanimously to recommend a single COVID-19 vaccine booster dose at least six months after completing an initial mRNA COVID-19 vaccine series, in the same risk groups for whom CDC recommended a Pfizer booster dose. These risk groups include people age 65 and older and residents in long-term care settings; people aged 50-64 with underlying medical conditions; people aged 18-49 with underlying medical conditions, based on their individual benefit and risks; and people aged 18-64 who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting, based on their individual benefits and risks. 

In addition, ACIP voted unanimously to recommend a single COVID-19 vaccine booster dose for adults at least two months after receiving an initial Johnson & Johnson COVID-19 vaccine dose. 

CDC’s director next will consider the ACIP recommendations.
 

Related News Articles

Headline
FDA seeks feedback on measuring AI-enabled medical device performance
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
Olympus recalls endoscope needles
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
ACIP recommends patients consult their provider for COVID-19 vaccine
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
FDA issues serious recall for electric wheelchair joysticks
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
CDC says COVID-19 cases growing or likely growing in 45 states 
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
FDA announces recall of cefazolin by Sandoz for mislabeling
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…